this post was submitted on 24 Mar 2025
512 points (100.0% liked)

Technology

67669 readers
4923 users here now

This is a most excellent place for technology news and articles.


Our Rules


  1. Follow the lemmy.world rules.
  2. Only tech related news or articles.
  3. Be excellent to each other!
  4. Mod approved content bots can post up to 10 articles per day.
  5. Threads asking for personal tech support may be deleted.
  6. Politics threads may be removed.
  7. No memes allowed as posts, OK to post as comments.
  8. Only approved bots from the list below, this includes using AI responses and summaries. To ask if your bot can be added please contact a mod.
  9. Check for duplicates before posting, duplicates may be removed
  10. Accounts 7 days and younger will have their posts automatically removed.

Approved Bots


founded 2 years ago
MODERATORS
you are viewing a single comment's thread
view the rest of the comments
[–] [email protected] 103 points 4 days ago (2 children)

They were being sued in the past for privacy breaches, they probably are in more trouble financially n than what's being reported?

Apparently they were just there to sell your genome data once you submit it, also there's no repeat customers since once you get your results you aren't going to get another one.

This article explains it better"https://www.standard.co.uk/news/science/23-and-me-dna-test-collapse-b1213426.html"

[–] [email protected] 29 points 4 days ago* (last edited 4 days ago) (1 children)

Good article. It was fundamentally not a good business model. You have to acquire new customers constantly just to keep the lights on, it’s unsustainable. Adding on top of that the expectations from investors to grow every year, and the collapse we see now is guatanteed.

I see they tried to diversify, that could have helped, but without a recurring revenue stream at the core of your business, you cannot become the big company they wanted to be.

[–] [email protected] 2 points 3 days ago* (last edited 3 days ago)

i was comparing it to THERANOS, more or less it was a scam from the start. Having someone like british pharm company glaxo-kline smith access to data without consent is just asking for trouble.

[–] [email protected] 16 points 4 days ago* (last edited 4 days ago)

Yes, just terrible management. They could have just made good money, but no, there has to be more. So excessive greed at any price - now it's just bankruptcy. But I'm sure that won't bother the senior management: they've already put their millions in a safe place and will simply move on. The next company that needs their outstanding leadership is bound to come along...